Autonomic Modulation After Spinal Anesthesia With Depth of Anesthesia and Vital Signs.
Department of Anaesthesiology, Taipei Veterans General Hospita, Taipei, Taiwan
1 other identifier
observational
46
1 country
1
Brief Summary
Spinal anaesthesia has the advantage that produced nerve block by the injection of local anaesthetic into cerebrospinal fluid (CSF). However, the greatest challenge in spinal anaesthesia is to control the spread of local anaesthetic through the CSF to provide a block which is adequate for the proposed surgery without unnecessary extensive spread, and increased risk of complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 16, 2019
CompletedFirst Submitted
Initial submission to the registry
February 12, 2020
CompletedFirst Posted
Study publicly available on registry
February 19, 2020
CompletedJuly 28, 2022
July 1, 2022
6 months
February 12, 2020
July 26, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
record and compare changes in ANS function( HRV and PPGA) after spinal anesthesia in different group
Electrocardiography and pulse photoplethysmography signals were recorded after spinal anesthesia. The spectrogram of beat-to-beat R-to-R intervals was derived by continuous wavelet transform (CWT), and the immediate power of high frequency (HFi) and low frequency (LFi) bands was extracted at 1-second intervals. The derived parameters, HF, LF, and pulse photoplethysmography amplitude, were normalized by their maximum and minimum values. Mixed-model regression and repeated-measures analysis of variance were used to explore the time-dependent effect.
maximum for 4 hours
Study Arms (2)
hyperbaric bupivacaine
The dosage of hyperbaric bupivacaine decided by the clinical anesthesiologist. This study is an observational study.
plain bupivacaine
The dosage of plain bupivacaine decided by the clinical anesthesiologist. This study is an observational study.
Interventions
ECG waveforms were continuously recorded using a multichannel polygraphic system (Embla N7000, Natus, Pleasanton, CA). The data were saved at a rate of 1024 Hz directly to a memory card within the device for offline analysis of heart rate variability (HRV) and PPG. All data included in the analysis were obtained from continuous artifact-free ECG recordings for analysis of the immediate effects of spinal anesthesia.
Eligibility Criteria
The investigators conducted a prospective observational study on patients who were scheduled to undergo elective surgery and spinal anesthesia. The investigators excluded patients who had recently been treated with a sedative, beta-blocker, parasympatholytic, or opioid agent, patients who had undergone emergency surgery, those with hypovolemia and hypothermia, arrhythmia, diabetes, or impairment of renal, hepatic, coagulation, cardiac, or respiratory function
You may qualify if:
- \. patients scheduled for operation with spinal anesthesia
You may not qualify if:
- recently treat with a sedative, beta-blocker, parasympatholytic, or opioid agent
- emergency surgery
- hypovolemia and hypothermia, arrhythmia, diabetes, or impairment of renal, hepatic, coagulation, cardiac, or respiratory function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Veterans General Hospital
Taipei, R.o.c, 11217, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 12, 2020
First Posted
February 19, 2020
Study Start
March 1, 2019
Primary Completion
August 16, 2019
Study Completion
August 16, 2019
Last Updated
July 28, 2022
Record last verified: 2022-07